• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

Month: June 2018

Animal Health

ADM Expands Health & Wellness Capabilities With Agreement to Acquire Probiotics International Limited

June 29, 2018 Staff Editor

Archer Daniels Midland Company (NYSE: ADM) announced today that it has reached an agreement to acquire Probiotics International Limited (PIL), a U.K.-based provider of probiotic supplements for human, pet, and production-animal use. The all-cash transaction […]

Animal Health

Studies of twin mice and twin men aim to discover effects of space on body’s microbiome

June 28, 2018 Staff Editor

Twenty laboratory mice are poised to play an important role in preparing humans to go to Mars. A Northwestern University-led study of the microbiome in space is one of five science investigations scheduled to launch […]

Finance

Chr. Hansen reports solid organic growth of 9% in the first nine months of 2017/18

June 28, 2018 Staff Editor

CEO Mauricio Graber: “We are pleased to report that we maintained the sales momentum in Q3″ Chr. Hansen reports solid organic revenue growth of 9% in the first nine months of 2017/18 (3% reported growth due to […]

Editor's Choice

Biotech Focus: Interview with Dr Edward Green, CHAIN Biotechnology

June 27, 2018 Staff Editor

Microbiome Times got in touch with Dr Edward Green, CEO of CHAIN Biotechology Ltd – a UK based microbiome Company focused on the development and commercialization of microbial technology for the production and delivery of biotherapeutics. Dr Edward […]

Pharma & Human Health

Lactobacillus reuteri Reduced Bone Loss in Older Women

June 26, 2018 Staff Editor

As reported on November 17, 2017 a randomized, double-blind, placebo-controlled study in 90 older women showed that supplementation of the probiotic strain Lactobacillus reuteri ATCC PTA 6475 decreased bone loss compared to placebo. The study […]

Finance

Kaleido Biosciences Raises $101 Million Series C Financing

June 26, 2018 Staff Editor

Kaleido Biosciences, a clinical-stage healthcare company leading the development of novel chemistries to drive functions of the microbiome organ, today announced that it has closed $101 million in an oversubscribed Series C financing. Several new […]

Pharma & Human Health

Study into the causes of Crohn’s disease hits major milestone

June 25, 2018 Staff Editor

After 10 years and a worldwide effort, Crohn’s and Colitis Canada is pleased to announce that the world-renowned Genetic, Environmental, Microbial (GEM) Project has reached its goal of 5,000 participants. Launched in 2008 at Mount […]

Finance

BioGaia appoints new Managing Director

June 25, 2018 Staff Editor

Previously, Isabelle Ducellier has held a number of senior international positions within the Pernod Ricard Group for 20 years, mainly within sales and marketing. She completed her career there as CEO and Board member of […]

Pharma & Human Health

MaaT Pharma and Lutech Sign Licensing Agreement on Microbiome Therapy for Graft-vs-Host Disease

June 21, 2018 Staff Editor

MaaT Pharma, a clinical-stage microbiome therapy company, and SATT Lutech, a private technology transfer company holding the exclusive rights to the scientific findings from research groups at Sorbonne University, APHP, CNRS and INSERM, today announced […]

Pharma & Human Health

DuPont Nutrition & Health Microbiome Venture Announces Third Strategic Academic Partnership

June 21, 2018 Staff Editor

Building upon the recently announced partnership with TFTAK in March 2018, the DuPont Nutrition & Health Microbiome Venture continues to strengthen its capabilities in announcing the third strategic research and development partnership. The newly forged […]

Pharma & Human Health

CosmosID Demonstrates Industry-Leading Performance for Strain-Level Microbiome Analysis in MOSAIC Challenge and PrecisionFDA Challenge

June 20, 2018 Staff Editor

CosmosID, a bioinformatics provider and NGS service laboratory, announced that the company’s cloud-based bioinformatics platform for microbiome analysis has received the highest score in the strain-level microbial profiling category of the Mosaic Community Challenge and […]

Posts navigation

1 2 3 »

Microbiome-based Diagnostics & Biomarkers: Free Market Report

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

Market Reports
October 26, 2020
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new [...]

Editor’s Choice

  • Fecal transplant turns cancer immunotherapy non-responders into responders
    February 10, 2021
  • Why microbiota samples should be collected in all clinical trials?
    January 26, 2021
  • Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
    January 20, 2021
  • Poor gut health connected to severe COVID-19, new review shows
    January 18, 2021
  • First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes
    September 25, 2020

ACCESS THE DECEMBER 2020 ISSUE:

Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Lallemand Health Solutions
  • Market Reports
  • Pharma & Human Health
  • Phytobiome & Environment
  • Premium Content
  • Reports
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter